Format

Send to

Choose Destination
Clin Immunol. 2013 Nov;149(2):251-64. doi: 10.1016/j.clim.2013.02.010. Epub 2013 Feb 28.

Autoimmune diseases and reproductive aging.

Author information

1
Partners Multiple Sclerosis Center, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: rbove@partners.org.

Abstract

As the population ages, more individuals with autoimmune diseases are experiencing reproductive senescence. Understanding the impact of menopause and age-related androgen decline on disease onset and course, as well as the potential for hormonal interventions, is critically important. In men, lupus erythematosis (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS) are associated with lower androgen levels. However, the impact of age-related declines in testosterone, as well as of testosterone replacement, on disease course remains underexplored. In women, the course of all three diseases with onset after the age of menopause differs from that with onset before menopause. Early age at menopause is associated with increased disease risk, and after menopause, disease course changes in SLE and RA. Less is known about MS. This article summarizes what is known about the relationship between reproductive aging and autoimmune diseases in men and women, and highlights areas for further investigation.

KEYWORDS:

Andropause;; Hormone replacement therapy; Menopause;; Multiple sclerosis;; Rheumatoid arthritis;; Systemic lupus erythematosus;

PMID:
23522436
PMCID:
PMC3805815
DOI:
10.1016/j.clim.2013.02.010
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center